
Sign up to save your podcasts
Or


Send us a text
We explore the cutting-edge science of extending dog lifespan through innovative drug development with Loyal founder and CEO Celine Halioua, who shares the company's groundbreaking approach to canine longevity and health.
In Science News:
• Cold water immersion after exercise shows no benefits for women despite its popularity among fitness influencers
In Pet Science:
• Brachycephalic dog and cat breeds now resemble each other more than their wild ancestors due to selective breeding
Our Guest Speaks about:
• Loyal's first drug mimics the longevity benefits of caloric restriction without reducing appetite
• Large dog breeds age faster due to persistently high growth hormone levels that weren't naturally selected for
• Loyal is conducting the largest animal health study ever with 1,300 dogs to test longevity interventions
• The company hopes to bring their first longevity drug to market within a year
• The goal is to add at least one healthier year to dogs' lives while improving quality of life during aging
• Aging dogs develop many of the same diseases as aging humans, making them excellent models for longevity research
Loyal: https://loyal.com/
Our links:
Our Website! www.bunsenbernerbmd.com
Sign up for our Weekly Newsletter!
Bunsen and Beaker on Twitter:
Bunsen and Beaker on TikTok
Support the show
For Science, Empathy, and Cuteness!
Being Kind is a Superpower.
All our social links are here!
By Jason and Kris Zackowski4.9
128128 ratings
Send us a text
We explore the cutting-edge science of extending dog lifespan through innovative drug development with Loyal founder and CEO Celine Halioua, who shares the company's groundbreaking approach to canine longevity and health.
In Science News:
• Cold water immersion after exercise shows no benefits for women despite its popularity among fitness influencers
In Pet Science:
• Brachycephalic dog and cat breeds now resemble each other more than their wild ancestors due to selective breeding
Our Guest Speaks about:
• Loyal's first drug mimics the longevity benefits of caloric restriction without reducing appetite
• Large dog breeds age faster due to persistently high growth hormone levels that weren't naturally selected for
• Loyal is conducting the largest animal health study ever with 1,300 dogs to test longevity interventions
• The company hopes to bring their first longevity drug to market within a year
• The goal is to add at least one healthier year to dogs' lives while improving quality of life during aging
• Aging dogs develop many of the same diseases as aging humans, making them excellent models for longevity research
Loyal: https://loyal.com/
Our links:
Our Website! www.bunsenbernerbmd.com
Sign up for our Weekly Newsletter!
Bunsen and Beaker on Twitter:
Bunsen and Beaker on TikTok
Support the show
For Science, Empathy, and Cuteness!
Being Kind is a Superpower.
All our social links are here!

38,457 Listeners

26,221 Listeners

37,443 Listeners

14,823 Listeners

171,989 Listeners

3,955 Listeners

12,209 Listeners

112,426 Listeners

24,388 Listeners

16,907 Listeners

21,862 Listeners

1,265 Listeners

85,647 Listeners

57,852 Listeners

10,586 Listeners